E6 can combine with cellular protein ubiquitin-protein ligase E3A (UBE3A) and initiate proteosomal degradation of p53, a well-known tumor suppressive gene [5], while E7 can induce degradation of pRb [3]. The gene discussed is UBE3A; the disease is neoplasm.